Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10

Jessica Hutchins, Rose Ann Barajas, Daniel Hale, Elia Escaname, Jane L Lynch

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The worrisome rise in pediatric type 2 diabetes (T2DM) is most prevalent among minority ethnic/racial populations. Typically, T2DM occurs during puberty in high risk obese adolescents with evidence of insulin resistance. Screening for T2DM in obese youth can be a daunting task for pediatricians and differentiating between pediatric T1DM and T2DM in obese youth can be challenging for pediatric endocrinologists. There is very limited data regarding the prevalence of T2DM among youth<10years of age. Here we present the case of a 5-year-old Hispanic male diagnosed with T2DM after referral by his pediatrician for abnormal weight gain, acanthosis nigricans and an elevated HbgA1c. He subsequently became symptomatic for diabetes with confirmed hyperglycemia and HbgA1c of 9.7% (83mmol/mol) at the time of formal diagnosis. Type 1 diabetes autoantibodies (GAD65, Islet, and ZincT8) and monogenic diabetes genetic tests were negative. Due to elevated liver enzymes and baseline HbgA1c, he received basal insulin as his initial therapy. In this paper, we will discuss this case and present an IRB approved retrospective review of the characteristics of the 20 T2DM patients <10years of age identified to date in our pediatric diabetes center. This review highlights that while uncommon, the diagnosis of T2DM merits consideration even in prepubertal children. This is especially true when working with a high risk population, such as our Hispanic South Texas youth.

Original languageEnglish (US)
JournalPediatric Diabetes
DOIs
StateAccepted/In press - 2016

Fingerprint

Type 2 Diabetes Mellitus
Pediatrics
Hispanic Americans
Acanthosis Nigricans
Research Ethics Committees
Puberty
Type 1 Diabetes Mellitus
Hyperglycemia
Autoantibodies
Population
Weight Gain
Insulin Resistance
Referral and Consultation
Insulin
Liver
Enzymes
Pediatricians
Therapeutics

Keywords

  • Early onset type 2 diabetes
  • Pediatric diabetes
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Internal Medicine
  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10. / Hutchins, Jessica; Barajas, Rose Ann; Hale, Daniel; Escaname, Elia; Lynch, Jane L.

In: Pediatric Diabetes, 2016.

Research output: Contribution to journalArticle

Hutchins, Jessica ; Barajas, Rose Ann ; Hale, Daniel ; Escaname, Elia ; Lynch, Jane L. / Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10. In: Pediatric Diabetes. 2016.
@article{13deae54fdd04415af57b07bb7841bfa,
title = "Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10",
abstract = "The worrisome rise in pediatric type 2 diabetes (T2DM) is most prevalent among minority ethnic/racial populations. Typically, T2DM occurs during puberty in high risk obese adolescents with evidence of insulin resistance. Screening for T2DM in obese youth can be a daunting task for pediatricians and differentiating between pediatric T1DM and T2DM in obese youth can be challenging for pediatric endocrinologists. There is very limited data regarding the prevalence of T2DM among youth<10years of age. Here we present the case of a 5-year-old Hispanic male diagnosed with T2DM after referral by his pediatrician for abnormal weight gain, acanthosis nigricans and an elevated HbgA1c. He subsequently became symptomatic for diabetes with confirmed hyperglycemia and HbgA1c of 9.7{\%} (83mmol/mol) at the time of formal diagnosis. Type 1 diabetes autoantibodies (GAD65, Islet, and ZincT8) and monogenic diabetes genetic tests were negative. Due to elevated liver enzymes and baseline HbgA1c, he received basal insulin as his initial therapy. In this paper, we will discuss this case and present an IRB approved retrospective review of the characteristics of the 20 T2DM patients <10years of age identified to date in our pediatric diabetes center. This review highlights that while uncommon, the diagnosis of T2DM merits consideration even in prepubertal children. This is especially true when working with a high risk population, such as our Hispanic South Texas youth.",
keywords = "Early onset type 2 diabetes, Pediatric diabetes, Type 2 diabetes mellitus",
author = "Jessica Hutchins and Barajas, {Rose Ann} and Daniel Hale and Elia Escaname and Lynch, {Jane L}",
year = "2016",
doi = "10.1111/pedi.12463",
language = "English (US)",
journal = "Pediatric Diabetes",
issn = "1399-543X",
publisher = "Blackwell Munksgaard",

}

TY - JOUR

T1 - Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10

AU - Hutchins, Jessica

AU - Barajas, Rose Ann

AU - Hale, Daniel

AU - Escaname, Elia

AU - Lynch, Jane L

PY - 2016

Y1 - 2016

N2 - The worrisome rise in pediatric type 2 diabetes (T2DM) is most prevalent among minority ethnic/racial populations. Typically, T2DM occurs during puberty in high risk obese adolescents with evidence of insulin resistance. Screening for T2DM in obese youth can be a daunting task for pediatricians and differentiating between pediatric T1DM and T2DM in obese youth can be challenging for pediatric endocrinologists. There is very limited data regarding the prevalence of T2DM among youth<10years of age. Here we present the case of a 5-year-old Hispanic male diagnosed with T2DM after referral by his pediatrician for abnormal weight gain, acanthosis nigricans and an elevated HbgA1c. He subsequently became symptomatic for diabetes with confirmed hyperglycemia and HbgA1c of 9.7% (83mmol/mol) at the time of formal diagnosis. Type 1 diabetes autoantibodies (GAD65, Islet, and ZincT8) and monogenic diabetes genetic tests were negative. Due to elevated liver enzymes and baseline HbgA1c, he received basal insulin as his initial therapy. In this paper, we will discuss this case and present an IRB approved retrospective review of the characteristics of the 20 T2DM patients <10years of age identified to date in our pediatric diabetes center. This review highlights that while uncommon, the diagnosis of T2DM merits consideration even in prepubertal children. This is especially true when working with a high risk population, such as our Hispanic South Texas youth.

AB - The worrisome rise in pediatric type 2 diabetes (T2DM) is most prevalent among minority ethnic/racial populations. Typically, T2DM occurs during puberty in high risk obese adolescents with evidence of insulin resistance. Screening for T2DM in obese youth can be a daunting task for pediatricians and differentiating between pediatric T1DM and T2DM in obese youth can be challenging for pediatric endocrinologists. There is very limited data regarding the prevalence of T2DM among youth<10years of age. Here we present the case of a 5-year-old Hispanic male diagnosed with T2DM after referral by his pediatrician for abnormal weight gain, acanthosis nigricans and an elevated HbgA1c. He subsequently became symptomatic for diabetes with confirmed hyperglycemia and HbgA1c of 9.7% (83mmol/mol) at the time of formal diagnosis. Type 1 diabetes autoantibodies (GAD65, Islet, and ZincT8) and monogenic diabetes genetic tests were negative. Due to elevated liver enzymes and baseline HbgA1c, he received basal insulin as his initial therapy. In this paper, we will discuss this case and present an IRB approved retrospective review of the characteristics of the 20 T2DM patients <10years of age identified to date in our pediatric diabetes center. This review highlights that while uncommon, the diagnosis of T2DM merits consideration even in prepubertal children. This is especially true when working with a high risk population, such as our Hispanic South Texas youth.

KW - Early onset type 2 diabetes

KW - Pediatric diabetes

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84997294871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997294871&partnerID=8YFLogxK

U2 - 10.1111/pedi.12463

DO - 10.1111/pedi.12463

M3 - Article

C2 - 27807935

AN - SCOPUS:84997294871

JO - Pediatric Diabetes

JF - Pediatric Diabetes

SN - 1399-543X

ER -